Mirum Pharmaceuticals Inc (MIRM)
25.84
+0.24
(+0.94%)
USD |
NASDAQ |
May 03, 16:00
25.82
-0.02
(-0.08%)
After-Hours: 20:00
Mirum Pharmaceuticals Gross Profit (Quarterly): 44.53M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 44.53M |
September 30, 2023 | 37.50M |
June 30, 2023 | 30.68M |
March 31, 2023 | 26.62M |
December 31, 2022 | 23.41M |
September 30, 2022 | 15.85M |
Date | Value |
---|---|
June 30, 2022 | 14.96M |
March 31, 2022 | 10.47M |
December 31, 2021 | 1.235M |
September 30, 2021 | 5.00M |
June 30, 2021 | 11.00M |
March 31, 2021 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2021
44.53M
Maximum
Dec 2023
18.44M
Average
15.40M
Median
Gross Profit (Quarterly) Benchmarks
Vanda Pharmaceuticals Inc | 41.81M |
Sarepta Therapeutics Inc | 362.90M |
Puma Biotechnology Inc | 47.86M |
Reneo Pharmaceuticals Inc | -- |
Tharimmune Inc | -- |